BeStock  
Stocks › Biotechnology › SGP

SpyGlass Pharma SGP

US equityMarket cap rank #3144Biotechnology
$30.43 −$0.35 (-1.14%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $30.43 0.00%
Open$30.12
Prev close$30.78
Day range$29.07 – $31.73
Volume108.9K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

SGP at a glance

SGP is priced at $30.43 right now, down 1.14% on the session. That puts its market value at $1.02B, 3144th largest among the 3753 stocks we cover.

Over a full year the shares have ranged across $17.06 to $39.92, which puts the current price roughly 58% of the way up that band.

On the chart it holds above both the 50-day ($29.07) and 200-day ($25.05) moving averages; RSI is 47, and the last 30 sessions moved at roughly 67% annualized volatility.

Revenue for the quarter ended Sep 2026 was $0.00, and a net loss of $24.25M.

4 analysts follow the stock and the average call is "buy". The mean target, $44.00, sits 44.6% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$18.10 / $49.44
Average price today$30.88
Volume108.9KAvg (90d) 104.9K
Turnover$3.36M
Turnover rate1.68%of shares outstanding
Volume ratio0.98vs. recent average pace
Day amplitude8.66%
Market cap$1.02B
Float market cap$197.69M
Shares outstanding6.50M
EPS (TTM)-$1.19
P/B4.84
Book value / share$6.29
Net profit (TTM)-$39.92M
Net assets$210.44M
30-day volatility66.7%annualized
Avg daily range (ATR)9.06%of price, 14 days
Max drawdown (1y)-40.8%-20.7% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

D
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

4 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$44.00+44.6% vs. current price
Consensus ratingBuy4 analysts covering
Morningstar fair value$43.63Price is below fair value

Wall Street’s average 12-month target is $44.00, 44.6% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $43.63, so shares trade 30.3% below that estimate. On earnings multiple, it sits in the 55th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.1%
1 week
-7.5%
1 month
+7.8%
3 months
+15.9%
6 months
+46.0%
Day range
$29.07$31.73
52-week range
$17.06$39.92

Technical signals

Full technicals →
Trend readLeaning bearish

3 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-7.8%Bearish
Price vs 50-day average+4.7%Bullish
Price vs 200-day average+21.5%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)47.1Bearish
MACD (12,26,9)0.68Bearish
Bollinger band position21%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How SGP ranks on BeStock

Market value#3131 of 3734
Closeness to 52-week high#1765 of 3724
Dollar volume today#2787 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

SGP is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on SGP.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on SGP

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

SGP stock: common questions

How is SpyGlass Pharma stock doing today?

$30.43 is the latest print for SGP, a move of -1.14% against yesterday's close of $30.78. Today's low and high so far: $29.07 and $31.73.

What is SGP worth in total?

Equity value comes to $1.02B at the current price. By that measure it is number 3144 of the 3753 names in our coverage.

Where does SGP sit in its 52-week range?

The year's floor is $17.06 and the ceiling $39.92. Shares are 23.8% away from that ceiling.

Does SGP send cash back through a dividend?

Our data shows no dividend paid by SpyGlass Pharma over the trailing twelve months.

Do Wall Street analysts like SGP?

Of 4 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $44.00, with the most cautious at $43.00 and the most optimistic at $45.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on SGP.

Sign in to join the discussion.

Scroll to Top